Bromide as a marker to measure adherence to drug therapy

European Journal of Clinical Pharmacology

Volumn 62, Issue 4, 2006, Pages 285-290

  Braam, Richard L ^a   Van Uum, Stan H M ^b   Russel, Frans G M ^a   Swinkels, Dorine W ^a   Thien, Theo ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Adherence; Bromide; Drug therapy

Indexed keywords

POTASSIUM BROMIDE;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; FEMALE; HUMAN; INTERRATER RELIABILITY; MALE; NORMAL HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

BROMIDES; DRUG MONITORING; HALF-LIFE; HUMANS; INTESTINAL ABSORPTION; PATIENT COMPLIANCE; REPRODUCIBILITY OF RESULTS;

EID: 33645679553     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-006-0103-5     Document Type: Article

References (18)

1. Urquhart J (1996) Patient non-compliance with drug regimens: measurement, clinical correlates, economic impact. Eur Heart J 17[suppl A]:8-15
2. Urquhart J (1994) Role of patient compliance in clinical pharmacokinetics. A review of recent research. Clin Pharmacokinet 27:202-215
3. Cramer JA, Scheyer RD, Mattson RH (1990) Compliance declines between clinic visits. Arch Intern Med 150:1509-1510
4. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487-497
5. Pullar T, Kumar S, Tindall H, Feely M (1989) Time to stop counting the tablets? Clin Pharmacol Ther 46:163-168
6. Roth HP, Caron HS, Bartholomew P (1970) Measuring intake of a prescribed medication, a bottle count and a tracer technique compared. Clin Pharmacol Ther 11:228-237
7. Mäenpää H, Javela K, Pikkarainen J, Mälkönen M, Heinonen OP, Manninen V (1987) Minimal doses of digoxin: A new marker for compliance to medication. Eur Heart J 8[suppl I]: 31-37
8. Feely M, Cooke J, Price D, Singleton S, Mehta A, Bradford L, Carlvert R (1987) Low-dose phenobarbitone as an indicator of compliance with drug therapy. Br J Clin Pharmacol 24:77-83
9. Ellard GA, Jenner PJ, Downs PA (1980) An evaluation of the potential use of isoniazid, acetylisoniazid and isonicotinic acid for monitoring the self-administration of drugs. Br J Clin Pharmacol 10:369-381
10. Ritschel WA, Vachharajani NN (1992) Review of electrolyte pharmacokinetics. Meth Find Exp Clin Pharmacol 14:241-254
11. Burnier M, Santschi V, Favrat B, Brunner HR (2003) Monitoring compliance in resistant hypertension: an important step in patient management. J Hypertens 21[suppl 2]:S37-S42
12. Miller ME, Cappon CJ (1984) Anion-exchange chromatographic determination of bromide in serum. Clin Chem 30:781-783
13. Vaiseman N, Koren G, Pencharz P (1986) Pharmacokinetics of oral and intravenous bromide in normal volunteers. J Toxicol Clin Toxicol 24:403-413
14. Pearce JMS (2002) Bromide, the first effective antiepileptic agent. J Neurol Neurosurg Psychiatry 72:412
15. van Gelderen CE, Savelkoul TJ, Blom JL, van Dokkum W, Kroes R (1993) The no-effect level of sodium bromide in healthy volunteers. Hum Exp Toxicol 12:9-14
16. Sangster B, Blom JL, Sekhuis VM, Loeber JG, Rauws AG, Koedam JC, Krajnc EI, van Logten MJ (1983) The influence of sodium bromide in man: a study in human volunteers with special emphasis on the endocrine and the central nervous system. Food Chem Toxicol 21:409-419
17. Toseland PA (1991) Bromide in blood. Lancet 338:386
18. Singer GG, Brenner BM (1998) Chapter 49: fluid and electrolyte disturbances. In: Fauci A, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL (eds) Harrison's principles of internal medicine, 14th edn. McGraw Hill, New York, pp 265-277